NMPA Approval

Compound Piracetam and Cerebroprotein Hydrolysate Tablets

Approval Number

国药准字H22026918

Company吉林显锋科技制药有限公司

Registration Date

July 22, 2019

Drug Information

Generic Name

复方吡拉西坦脑蛋白水解物片

Brand Name

麦达欣

Dosage Form

片剂

Strength

复方

Drug Type

化学药品

Registration Date

July 22, 2019

Company Information

Applicant Company

Company Name吉林显锋科技制药有限公司

Manufacturing Company

Company Name吉林显锋科技制药有限公司

Company Address

农安县显锋街9号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

复方吡拉西坦脑蛋白水解物片 - NMPA 批准文号 | MedPath